Callan Family Office, LLC

Family Office

Position in ELAN — Elanco Animal Health Inc

CIK 1938970 RADNOR, PA

Position in ELAN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,932,081

+$148,640 QoQ

Shares Held

164,316

-1.7% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Callan Family Office, LLC holds $21,578,279 across 11 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (18.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	734,570	$7,353,045
2	ELAN	Elanco Animal Health Inc This page	164,316	$3,932,081
3	TAK	Takeda Pharmaceutical Co Ltd	162,957	$3,017,963
4	ZTS	Zoetis Inc.	21,685	$2,563,383
5	TEVA	Teva Pharmaceutical Industries Ltd	63,254	$1,905,210
6	UTHR	UNITED THERAPEUTICS Corp	2,083	$1,235,177
7	PBH	Prestige Consumer Healthcare Inc.	8,666	$513,633
8	HIMS	Hims & Hers Health, Inc.	18,020	$374,095

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,932,081	164,316	-1.7%	Shares	Sole	2026-05-13
2025-12-31	$3,783,441	167,187	+4.9%	Shares	Sole	2026-02-12
2025-09-30	$3,208,724	159,321	-4.1%	Shares	Sole	2025-11-04
2025-06-30	$2,373,307	166,198	+239.0%	Shares	Sole	2025-07-24
2025-03-31	$514,752	49,024	+33.5%	Shares	Sole	2025-05-13
2024-12-31	$444,679	36,720	+219.3%	Shares	Sole	2025-02-07
2023-03-31	$108,100	11,500	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.